000 | 01009 a2200277 4500 | ||
---|---|---|---|
005 | 20250517065457.0 | ||
264 | 0 | _c20160229 | |
008 | 201602s 0 0 eng d | ||
022 | _a1756-1833 | ||
024 | 7 |
_a10.1136/bmj.h6431 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCohen, Deborah | |
245 | 0 | 0 |
_aData on trial of anticoagulant is to be reanalyzed after discovery that investigators used faulty device. _h[electronic resource] |
260 |
_bBMJ (Clinical research ed.) _cDec 2015 |
||
300 |
_ah6431 p. _bdigital |
||
500 | _aPublication Type: News | ||
650 | 0 | 4 |
_aAtrial Fibrillation _xblood |
650 | 0 | 4 | _aEquipment Failure |
650 | 0 | 4 |
_aFactor Xa Inhibitors _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInternational Normalized Ratio _xinstrumentation |
650 | 0 | 4 |
_aRivaroxaban _xtherapeutic use |
650 | 0 | 4 |
_aStroke _xblood |
773 | 0 |
_tBMJ (Clinical research ed.) _gvol. 351 _gp. h6431 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.h6431 _zAvailable from publisher's website |
999 |
_c25512635 _d25512635 |